IRWD
Ironwood Pharmaceuticals Inc
NASDAQ: IRWD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.09
-2.65% today
Updated 2026-06-05
Market cap
$544.87M
P/E ratio
5.34
P/S ratio
1.51x
EPS (TTM)
$0.62
Dividend yield
—
52W range
$1 – $6
Volume
2.2M
Ironwood Pharmaceuticals Inc (IRWD) Insider transactions
Net insider activity
Net selling (4,250,488 shares)
Buy transactions
54
Sell transactions
46
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | SILVER, RONALD | PFO & PAO | Buy | 25,000 | — | — |
| 2026-03-17 | DENNER, ALEXANDER J | Director | Sale | 6,725,000 | $3.05 | $20.51M |
| 2026-03-17 | DENNER, ALEXANDER J | Director | Sale | 5,800 | $3.31 | $19198.00 |
| 2026-03-13 | DENNER, ALEXANDER J | Director | Buy | 4,451 | — | — |
| 2026-03-10 | SILVER, RONALD | Principal Accounting Officer | Buy | 163,934 | — | — |
| 2026-03-10 | SHETZLINE, MICHAEL | SVP, CMO, Head-Res&Drug | Buy | 136,612 | — | — |
| 2026-03-10 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Buy | 409,836 | — | — |
| 2026-03-10 | MARTINI, GREGORY S. | Chief Financial Officer | Buy | 136,612 | — | — |
| 2026-03-10 | JOHN, MINARDO | Chief Legal Officer | Buy | 136,612 | — | — |
| 2026-03-10 | GASKINS, TAMMI L | Chief Commercial Officer | Buy | 136,612 | — | — |
| 2026-02-24 | SILVER, RONALD | Principal Accounting Officer | Sale | 12,621 | $3.66 | $46192.86 |
| 2026-02-24 | SHETZLINE, MICHAEL | SVP, CMO, Head-Res&Drug | Buy | 17,012 | $3.66 | $62263.92 |
| 2026-02-24 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 103,526 | $3.66 | $378905.16 |
| 2026-02-24 | MARTINI, GREGORY S. | Chief Financial Officer | Sale | 11,457 | $3.66 | $41932.62 |
| 2026-02-24 | JOHN, MINARDO | Chief Legal Officer | Sale | 19,053 | $3.66 | $69733.98 |
| 2026-02-24 | GASKINS, TAMMI L | Chief Commercial Officer | Sale | 11,239 | $3.66 | $41134.74 |
| 2026-02-23 | SILVER, RONALD | Principal Accounting Officer | Sale | 11,552 | $3.81 | $44013.12 |
| 2026-02-23 | SHETZLINE, MICHAEL | SVP, CMO, Head-Res&Drug | Sale | 15,570 | $3.81 | $59321.70 |
| 2026-02-23 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 94,757 | $3.81 | $361024.17 |
| 2026-02-23 | MARTINI, GREGORY S. | Chief Financial Officer | Sale | 10,487 | $3.81 | $39955.47 |
| 2026-02-23 | JOHN, MINARDO | Chief Legal Officer | Sale | 17,439 | $3.81 | $66442.59 |
| 2026-02-23 | GASKINS, TAMMI L | Chief Commercial Officer | Sale | 10,287 | $3.81 | $39193.47 |
| 2026-01-05 | SILVER, RONALD | Principal Accounting Officer | Sale | 35,416 | $4.60 | $162913.60 |
| 2025-12-15 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 4,178 | — | — |
| 2025-11-17 | GASKINS, TAMMI L | Chief Commercial Officer | Sale | 6,016 | $3.32 | $19973.12 |
| 2025-09-15 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 11,718 | — | — |
| 2025-08-11 | SILVER, RONALD | Principal Accounting Officer | Sale | 2,846 | $0.84 | $2390.64 |
| 2025-08-11 | MARTINI, GREGORY S. | Chief Financial Officer | Sale | 1,265 | $0.84 | $1062.60 |
| 2025-08-11 | JOHN, MINARDO | Chief Legal Officer | Sale | 7,754 | $0.84 | $6513.36 |
| 2025-08-11 | GASKINS, TAMMI L | Chief Commercial Officer | Sale | 1,316 | $0.84 | $1105.44 |
| 2025-06-13 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 24,193 | — | — |
| 2025-06-10 | SHEPARD, JAY | Director | Buy | 45,000 | — | — |
| 2025-06-10 | MOUKHEIBIR, CATHERINE | Director | Buy | 45,000 | — | — |
| 2025-06-10 | MCHUGH, JULIE | Director | Buy | 45,000 | — | — |
| 2025-06-10 | KESSLER, MARLA L | Director | Buy | 45,000 | — | — |
| 2025-06-10 | DUANE, JON R | Director | Buy | 45,000 | — | — |
| 2025-06-10 | DREYFUS, ANDREW | Director | Buy | 45,000 | — | — |
| 2025-06-10 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 45,000 | — | — |
| 2025-06-10 | CURRIE, MARK G | Director | Buy | 45,000 | — | — |
| 2025-05-20 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Buy | 540,000 | — | — |
| 2025-05-16 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 13,353 | $0.58 | $7744.74 |
| 2025-05-16 | GASKINS, TAMMI L | Chief Commercial Officer | Sale | 2,563 | $0.58 | $1486.54 |
| 2025-04-02 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 10,416 | — | — |
| 2025-02-10 | SILVER, RONALD | Principal Accounting Officer | Sale | 12,048 | $1.76 | $21204.48 |
| 2025-02-10 | SHETZLINE, MICHAEL | SVP, CMO, Head-Res&Drug | Buy | 133,333 | — | — |
| 2025-02-10 | SHETZLINE, MICHAEL | SVP, CMO, Head-Res&Drug | Sale | 41,269 | $1.76 | $72633.44 |
| 2025-02-10 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 139,064 | $1.76 | $244752.64 |
| 2025-02-10 | MARTINI, GREGORY S. | Chief Financial Officer | Sale | 12,052 | $1.76 | $21211.52 |
| 2025-02-10 | JOHN, MINARDO | Chief Legal Officer | Buy | 122,222 | — | — |
| 2025-02-10 | JOHN, MINARDO | Chief Legal Officer | Sale | 38,938 | $1.76 | $68530.88 |
| 2025-01-27 | SILVER, RONALD | Principal Accounting Officer | Buy | 133,333 | — | — |
| 2025-01-27 | MARTINI, GREGORY S. | Chief Financial Officer | Buy | 111,111 | — | — |
| 2025-01-17 | SHETZLINE, MICHAEL | SVP, CMO, Head-Res&Drug | Buy | 48,224 | — | — |
| 2025-01-17 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Buy | 147,354 | — | — |
| 2025-01-17 | JOHN, MINARDO | Chief Legal Officer | Buy | 40,187 | — | — |
| 2024-12-16 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 4,249 | — | — |
| 2024-11-18 | EMANY, SRAVAN KUMAR | SVP, COO and CFO | Sale | 11,001 | $4.08 | $44884.08 |
| 2024-11-18 | DAVIS, ANDREW | SVP, Chief Business Officer | Sale | 5,360 | $4.08 | $21868.80 |
| 2024-09-16 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 3,282 | — | — |
| 2024-08-12 | SILVER, RONALD | Principal Accounting Officer | Sale | 3,107 | $4.27 | $13266.89 |
| 2024-08-12 | JOHN, MINARDO | Chief Legal Officer | Sale | 9,910 | $4.27 | $42315.70 |
| 2024-06-18 | SHEPARD, JAY | Director | Buy | 24,311 | — | — |
| 2024-06-18 | MOUKHEIBIR, CATHERINE | Director | Buy | 24,311 | — | — |
| 2024-06-18 | MCHUGH, JULIE | Director | Buy | 24,311 | — | — |
| 2024-06-18 | KESSLER, MARLA L | Director | Buy | 24,311 | — | — |
| 2024-06-18 | DUANE, JON R | Director | Buy | 24,311 | — | — |
| 2024-06-18 | DREYFUS, ANDREW | Director | Buy | 24,311 | — | — |
| 2024-06-18 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 24,311 | — | — |
| 2024-06-18 | CURRIE, MARK G | Director | Buy | 24,311 | — | — |
| 2024-06-15 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 2,572 | — | — |
| 2024-06-10 | MCHUGH, JULIE | Director | Sale | 22,766 | $6.29 | $143198.14 |
| 2024-06-07 | MOUKHEIBIR, CATHERINE | Director | Sale | 35,574 | $6.61 | $235144.14 |
| 2024-06-06 | MOUKHEIBIR, CATHERINE | Director | Sale | 44,426 | $6.36 | $282549.36 |
| 2024-05-20 | SHETZLINE, MICHAEL | CMO,SVP,Head-Res&Drug | Sale | 16,128 | $6.45 | $104025.60 |
| 2024-05-20 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 67,618 | $6.45 | $436136.10 |
| 2024-05-20 | JOHN, MINARDO | Chief Legal Officer | Sale | 17,404 | $6.45 | $112255.80 |
| 2024-05-20 | DAVIS, ANDREW | SVP, Chief Business Officer | Sale | 22,725 | $6.45 | $146576.25 |
| 2024-05-16 | EMANY, SRAVAN KUMAR | SVP, Chief Financial Officer | Sale | 18,280 | $6.64 | $121379.20 |
| 2024-03-15 | DENNER, ALEXANDER J | Director, 10% Owner | Buy | 1,662 | — | — |
| 2024-03-08 | SHETZLINE, MICHAEL | CMO,SVP,Head-Res&Drug | Sale | 34,936 | — | — |
| 2024-03-08 | SHETZLINE, MICHAEL | CMO,SVP,Head-Res&Drug | Buy | 34,936 | — | — |
| 2024-03-08 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 120,298 | — | — |
| 2024-03-08 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Buy | 120,298 | — | — |
| 2024-03-08 | JOHN, MINARDO | Chief Legal Officer | Sale | 32,752 | — | — |
| 2024-03-08 | JOHN, MINARDO | Chief Legal Officer | Buy | 32,752 | — | — |
| 2024-03-08 | EMANY, SRAVAN KUMAR | SVP, Chief Financial Officer | Sale | 37,120 | — | — |
| 2024-03-08 | EMANY, SRAVAN KUMAR | SVP, Chief Financial Officer | Buy | 37,120 | — | — |
| 2024-03-08 | DAVIS, ANDREW | SVP, Chief Business Officer | Sale | 37,120 | — | — |
| 2024-03-08 | DAVIS, ANDREW | SVP, Chief Business Officer | Buy | 37,120 | — | — |
| 2024-03-06 | DUANE, JON R | Director | Buy | 6,920 | $8.70 | $60204.00 |
| 2024-03-05 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Buy | 132,438 | — | — |
| 2024-03-05 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Buy | 264,876 | — | — |
| 2024-03-04 | EMANY, SRAVAN KUMAR | SVP, Chief Financial Officer | Buy | 10,684 | $9.38 | $100215.92 |
| 2024-02-12 | SILVER, RONALD | Principal Accounting Officer | Buy | 27,213 | — | — |
| 2024-02-12 | SILVER, RONALD | Principal Accounting Officer | Sale | 7,908 | $15.24 | $120517.92 |
| 2024-02-12 | SHETZLINE, MICHAEL | CMO,SVP,Head-Res&Drug | Buy | 27,214 | — | — |
| 2024-02-12 | SHETZLINE, MICHAEL | CMO,SVP,Head-Res&Drug | Buy | 54,427 | — | — |
| 2024-02-12 | SHETZLINE, MICHAEL | CMO,SVP,Head-Res&Drug | Sale | 38,618 | $15.24 | $588538.32 |
| 2024-02-12 | MCCOURT, THOMAS A | Director, Chief Executive Officer | Sale | 177,164 | $15.24 | $2.70M |
| 2024-02-12 | JOHN, MINARDO | Chief Legal Officer | Buy | 27,214 | — | — |
Frequently asked questions
Are IRWD insiders buying or selling?
Over the transactions on record, IRWD insiders have been net buyers, with about $27.46M in stock sold across 46 sales, against 3 open-market purchases.
Does insider selling at IRWD mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which IRWD insiders are selling the most?
Recent selling is concentrated in a few names. DENNER, ALEXANDER J accounts for the largest share on record, with about $20.53M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.